Acutus Medical (AFIB) Environmental, Social & Governance (ESG) Data

Company Profile

Search within these filings

View filings

Exhibits within filings

Filing insights

Export filings list

Export a CSV file of filings or unique filing companies (up to first 5,000 results).

Download list of filings Download list of companies

Employees

Data from SEC filings

Employee count

ESG framework mentions

In last year of SEC filings

Sustainability Accounting Standards Board (SASB)

No mentions

Global Reporting Initiative (GRI)

No mentions

Task Force on Climate-related Financial Disclosures (TCFD)

No mentions

UN Sustainable Development Goals (SDGs)

No mentions

ESG term mentions

In last year of SEC filings

Conservation Environment Environmental Materials Nature Offset Oil Packaging Pandemic Raw Materials Recycling Waste Access African American Asian Benefits Black California Consumer Privacy Act Charitable Collective Bargaining Community Culture Customer Customer Satisfaction Cyber Cybersecurity Data Privacy Data Security Death Demographic Disability Diversity Employee Employee Retention Engagement Ethnicity Gender General Data Protection Regulation Health and Safety Health Care Healthcare Hire Hiring Hispanic Human Capital Human Resources Incident Injured Injuries Injury Latinx LGBTQ Privacy Product Quality Product Safety Recall Recruit Recruitment Reimbursement Retention Retirement Safety Satisfaction Skill Skilled Skills Social Society Stakeholder Supplier Supply Chain Talent Training Union Volunteer Women Workforce Anti-corruption Anticorruption Antitrust Assessment Assurance Attorney General Audit Bonus Bribe Bribery Chronic Class Action Lawsuit Classified Classified Board Commitment Conflict of Interest Corporate Governance Corruption Department of Director Resignation Ethics Executive Compensation Expert Fraud Goals Governance Hedging Incentive Incentivize Independence Independent Innovate Innovation Innovative Investigation Lawsuit Lead Independent Director Leadership Litigation Long-term Majority Mission Oversee Oversight Plaintiff Procurement Purpose R&D Reputation Reputational Research and Development Responsibility Responsible Self-evaluation Special Meeting Strategy Sustainable Targets Tax Transparency Transparent Voting Rights

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM

On June 16, 2022, Acutus Medical, Inc. (the “Company”) held its Annual Meeting of Stockholders (the “Annual Meeting”). The Company’s definitive proxy statement for the Annual Meeting was filed with the U.S. Securities and Exchange Commission (the “SEC”) on April 28, 2022 and describes in detail both of the two proposed voting matters (the “Proposals”) submitted to the Company’s stockholders at the Annual Meeting. The final results for the votes cast with respect to each Proposal, rounded to the nearest whole share, are set forth below.

As of April 18, 2022, the record date of the Annual Meeting, there were 28,336,285 outstanding shares of the Company’s common stock. At the Annual Meeting, a quorum of 18,546,772 shares of the Company’s common stock were represented in person or by proxy.

Proposal 1

The stockholders elected each of R. Scott Huennekens, Shaden Marzouk, MD and Andrew ElBardissi, MD, as a Class II director to hold office until the 2025 Annual Meeting of Stockholders, and in each case until their respective successors are duly elected and qualified, by the following vote:

Nominee	Votes For	Votes Withheld	Broker Non-Votes
R. Scott Huennekens	11,253,733	2,114,322	5,178,717
Shaden Marzouk, MD	11,680,619	1,687,436	5,178,717
Andrew ElBardissi, MD	11,844,930	1,523,125	5,178,717

Proposal 2

The stockholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022 by the following vote:

Votes For	Votes Against	Abstentions
18,463,128	34,571	49,073

No other items were presented for stockholder approval at the Annual Meeting.